ES2170501T3 - Composicion farmaceutica antivirica que comprende acido glicirrizico y al menos una proteina que posee actividad antivirica. - Google Patents

Composicion farmaceutica antivirica que comprende acido glicirrizico y al menos una proteina que posee actividad antivirica.

Info

Publication number
ES2170501T3
ES2170501T3 ES98925588T ES98925588T ES2170501T3 ES 2170501 T3 ES2170501 T3 ES 2170501T3 ES 98925588 T ES98925588 T ES 98925588T ES 98925588 T ES98925588 T ES 98925588T ES 2170501 T3 ES2170501 T3 ES 2170501T3
Authority
ES
Spain
Prior art keywords
protein
pharmaceutical composition
activity
glycyrdic
antivirical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98925588T
Other languages
English (en)
Spanish (es)
Inventor
Raffaello Pompei
Mario Pinza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angelini Acraf SpA
Original Assignee
Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini Francesco ACRAF SpA filed Critical Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Application granted granted Critical
Publication of ES2170501T3 publication Critical patent/ES2170501T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES98925588T 1997-05-14 1998-05-06 Composicion farmaceutica antivirica que comprende acido glicirrizico y al menos una proteina que posee actividad antivirica. Expired - Lifetime ES2170501T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI001119A IT1291366B1 (it) 1997-05-14 1997-05-14 Composizione farmaceutica antivirale comprendente acido glicirrizico ed almeno una proteina dotata di attivita' antivirale

Publications (1)

Publication Number Publication Date
ES2170501T3 true ES2170501T3 (es) 2002-08-01

Family

ID=11377123

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98925588T Expired - Lifetime ES2170501T3 (es) 1997-05-14 1998-05-06 Composicion farmaceutica antivirica que comprende acido glicirrizico y al menos una proteina que posee actividad antivirica.

Country Status (26)

Country Link
US (1) US6329339B1 (OSRAM)
EP (1) EP0980254B1 (OSRAM)
JP (2) JP2001525814A (OSRAM)
KR (1) KR100592193B1 (OSRAM)
CN (1) CN1114447C (OSRAM)
AR (1) AR012849A1 (OSRAM)
AT (1) ATE212232T1 (OSRAM)
AU (1) AU740944B2 (OSRAM)
BG (1) BG64748B1 (OSRAM)
CA (1) CA2289550A1 (OSRAM)
CZ (1) CZ291932B6 (OSRAM)
DE (1) DE69803565T2 (OSRAM)
DK (1) DK0980254T3 (OSRAM)
EA (1) EA003126B1 (OSRAM)
ES (1) ES2170501T3 (OSRAM)
GE (1) GEP20022672B (OSRAM)
HU (1) HU224956B1 (OSRAM)
IL (2) IL132651A0 (OSRAM)
IT (1) IT1291366B1 (OSRAM)
PL (1) PL189218B1 (OSRAM)
PT (1) PT980254E (OSRAM)
SK (1) SK283584B6 (OSRAM)
TR (1) TR199902730T2 (OSRAM)
UA (1) UA63955C2 (OSRAM)
WO (1) WO1998051334A1 (OSRAM)
ZA (1) ZA983917B (OSRAM)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7151082B2 (en) * 1999-02-11 2006-12-19 The Feinstein Institute For Medical Research Antagonists of HMG1 for treating inflammatory conditions
US6303321B1 (en) 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
US7304034B2 (en) 2001-05-15 2007-12-04 The Feinstein Institute For Medical Research Use of HMGB fragments as anti-inflammatory agents
AU2003225073A1 (en) * 2002-04-18 2003-11-03 The University Of Iowa Research Foundation Methods of inhibiting and treating bacterial biofilms by metal chelators
US7696169B2 (en) * 2003-06-06 2010-04-13 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
CA2882022A1 (en) * 2003-09-11 2005-03-24 Walter Newman Monoclonal antibodies against hmgb1
US7964706B2 (en) * 2004-10-22 2011-06-21 Medimmune, Llc High affinity antibodies against HMGB1 and methods of use thereof
WO2007011606A2 (en) * 2005-07-18 2007-01-25 Critical Therapeutics, Inc. USE OF HMGBl ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY SKIN CONDITIONS
IT1391170B1 (it) * 2008-08-07 2011-11-18 D M G Italia S R L Composizione topica intra-nasale utilizzabile in caso di ostruzione nasale
CA2809031C (en) * 2010-08-25 2018-10-16 Weijian Zhang Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis
US9416151B2 (en) 2010-08-25 2016-08-16 Lurong ZHANG Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis
US20170049863A1 (en) * 2014-02-21 2017-02-23 National University Corporation Tokyo University Of Marine Science And Technology Norovirus deactivator and method for producing same, method for deactivating norovirus, method for producing lysozyme component for norovirus deactivation use, prophylactic or therapeutic agent for norovirus infection, and external preparation for skin for norovirus deactivation purposes
US12447166B2 (en) 2016-02-25 2025-10-21 Applied Biological Laboratories, Inc. Compositions and methods for protecting against airborne pathogens and irritants
SG11201806868TA (en) * 2016-02-25 2018-09-27 Applied Biological Laboratories Inc Compositions and methods for protecting against airborne pathogens and irritants
CN109022351B (zh) * 2018-09-28 2021-10-19 广州奇龙生物科技有限公司 重组人溶菌酶的新应用
EP3928785B1 (en) * 2020-04-27 2024-07-31 Guangzhou Century Clinical Research Co., Ltd Medicament and food for use in preventing or treating novel coronavirus pneumonia covid-19
CN112135625B (zh) * 2020-04-27 2021-07-06 广州新创忆药物临床研究有限公司 一种预防或治疗covid-19新冠肺炎的药物及其应用
JP7543427B2 (ja) * 2020-04-27 2024-09-02 広州新創憶薬物臨床研究有限公司 抗新型コロナウイルス感染症の医薬品、食品、及び使用
MX2021005280A (es) * 2021-05-04 2022-02-23 Spv Timser S A P I De C V Composicion farmaceutica que contiene triterpenoides pentaciclicos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH085800B2 (ja) * 1986-12-19 1996-01-24 エーザイ株式会社 塩化リゾチ−ム及びグリチルリチン酸ジカリウム含有水溶液製剤
JP2838720B2 (ja) * 1989-10-31 1998-12-16 ゼリア新薬工業株式会社 安定な点眼剤
JP4056099B2 (ja) * 1996-05-09 2008-03-05 森永乳業株式会社 水生動物の寄生生物性疾患の予防および治療剤

Also Published As

Publication number Publication date
US6329339B1 (en) 2001-12-11
EP0980254A1 (en) 2000-02-23
CZ291932B6 (cs) 2003-06-18
PL189218B1 (pl) 2005-07-29
CN1114447C (zh) 2003-07-16
KR100592193B1 (ko) 2006-06-23
DE69803565T2 (de) 2002-08-08
DK0980254T3 (da) 2002-05-06
AR012849A1 (es) 2000-11-22
ZA983917B (en) 1998-11-09
UA63955C2 (uk) 2004-02-16
CN1255859A (zh) 2000-06-07
GEP20022672B (en) 2002-04-25
ITMI971119A0 (OSRAM) 1997-05-14
CZ399199A3 (cs) 2000-04-12
HK1028347A1 (en) 2001-02-16
JP2009102370A (ja) 2009-05-14
EA199901024A1 (ru) 2000-06-26
PT980254E (pt) 2002-07-31
WO1998051334A1 (en) 1998-11-19
EA003126B1 (ru) 2003-02-27
AU7764698A (en) 1998-12-08
ITMI971119A1 (it) 1998-11-14
PL336802A1 (en) 2000-07-17
IL132651A0 (en) 2001-03-19
IL132651A (en) 2006-10-31
HUP0002985A3 (en) 2001-04-28
CA2289550A1 (en) 1998-11-19
SK154499A3 (en) 2000-08-14
KR20010012419A (ko) 2001-02-15
JP2001525814A (ja) 2001-12-11
BG64748B1 (bg) 2006-02-28
EP0980254B1 (en) 2002-01-23
IT1291366B1 (it) 1999-01-07
BG103968A (en) 2000-07-31
HU224956B1 (en) 2006-04-28
ATE212232T1 (de) 2002-02-15
TR199902730T2 (xx) 2000-02-21
DE69803565D1 (de) 2002-03-14
HUP0002985A2 (hu) 2001-01-29
SK283584B6 (sk) 2003-10-07
AU740944B2 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
ES2170501T3 (es) Composicion farmaceutica antivirica que comprende acido glicirrizico y al menos una proteina que posee actividad antivirica.
NL300190I1 (nl) Farmaceutische formuleringen met darifenacine.
BR9611367A (pt) Formulação farmacêutic liofilizada estável
BR9607851B1 (pt) combinaÇço e formulaÇço farmacÊutica.
ID24654A (id) Formulasi farmasi omeprazola
DE69814091D1 (de) Voriconazol-enthaltende pharmazeutische zubereitungen
DE69810612D1 (de) Pharmazeutische Zusammensetzungen mit Plasmaproteinen
ID21259A (id) Sistim penyaluran obat untuk dua atau lebih bahan-bahan aktif
DE69525148D1 (de) Pharmazeutische formulierung
PT911340E (pt) Isoquinolinas-3-carboxamidas substituidas, sua preparacao e utilizacao como farmacos
DK0850426T3 (da) Transpondearrangement
IS5425A (is) Læknislyf
NO981008D0 (no) Farmasöytisk formulering
DE69014498D1 (de) Hyposensibilisierende wirksame Substanz.
FI961437A0 (fi) Vaikuttavan aineen luovuttava systeemi
FI904584A0 (fi) Aktiv matrisvaetskekristalldisplay.
DE69014166D1 (de) Aktive Matrix.
EE04685B1 (et) Ravimi l„bimiskiirust kontrolliv membraan v?i maatriks
DE68917651D1 (de) Aktiv-Matrix-Anzeigevorrichtung.
TR199501082A2 (tr) Farmasötik formülasyonlar.
FI903613A7 (fi) Luovutussysteemi aktiiviaineita varten
FI955605A0 (fi) Aryloivia lääkkeitä
DE69013610D1 (de) Aktives Matrixanzeigegerät.
FI973230A7 (fi) Uusi farmaseuttinen formulaatio
DK0758905T3 (da) Hirudinholdige farmaceutiske præparater

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 980254

Country of ref document: ES